NCT06010524 (VOSEVI_Reg) is a clinical trial in Hepatitis C, sponsored by Cerrahpasa Medical Faculty Foundation.

Who is sponsoring NCT06010524?

NCT06010524 is sponsored by Cerrahpasa Medical Faculty Foundation.

What condition does NCT06010524 study?

NCT06010524 studies Hepatitis C.

Is NCT06010524 still recruiting?

NCT06010524 is currently status unknown. Last updated 29 August 2023.

Last reviewed 2023-08-29 · How we verify

NCT06010524: VOSEVI_Reg

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Study of Chronic Hepatitis C Patients Treated With SOF/VEL/VOX

Status unknown Last updated 29 August 2023

What this trial tests

trial in Hepatitis C in 450 participants. Status unknown.

Timeline

1 February 2023

Primary endpoint
31 December 2023

31 December 2023

Quick facts

Lead sponsor	Cerrahpasa Medical Faculty Foundation
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	450
Start date	1 February 2023
Primary completion	31 December 2023
Estimated completion	31 December 2023
Sites	1 location across Turkey (Türkiye)

Conditions studied

Hepatitis C — all drugs for Hepatitis C →

Sponsor

Cerrahpasa Medical Faculty Foundation

Who can join

18 and older, any sex, with Hepatitis C. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a retrospective, non-interventional study. Investigators from infectious diseases and gastroenterology departments will participate this study. Patients data will be collected from hospital medical records.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hepatitis C

Currently open trials in the same condition.

NCT06263829 — HCV Tappt Adherence Study · NA · recruiting
NCT06179498 — Partner Navigation Intervention for Hepatitis C Treatment Among Young People Who Inject Drugs · NA · recruiting
NCT06367465 — Feasibility and Acceptability of HCV Treatment in Pregnancy · recruiting
NCT05668780 — Buprenorphine Integration Research and Community Health · NA · active not recruiting
NCT05208697 — Tele-Harm Reduction · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06010524 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cerrahpasa Medical Faculty Foundation
Last refreshed: 29 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06010524.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing